Insulin reduces obesity-related inflammation

Key points
- Scientists have found that one of the most common side effects of obesity – inflammation – can be fought by administering insulin.
- As an added benefit, the team behind the work says, this also reduces a person's risk of developing diabetes.
- The remarkable finding was recently presented in a new thesis, written by experts at the Sahlgrenska Academy of the University of Gothenburg, in Sweden.
- When you put on weight, your fat tissue grows and begins to produce a wealth of inflammatory molecules.
Scientists have found that one of the most common side effects of obesity – inflammation – can be fought by administering insulin.
As an added benefit, the team behind the work says, this also reduces a person's risk of developing diabetes.
The remarkable finding was recently presented in a new thesis, written by experts at the Sahlgrenska Academy of the University of Gothenburg, in Sweden.
When you put on weight, your fat tissue grows and begins to produce a wealth of inflammatory molecules.
The increase in these inflammatory molecules leaves the fat tissue in a state of chronic inflammation.
This plays an important role in the development of insulin resistance, an early stage of type 2 diabetes, where the body is unable to regulate blood sugar levels using its own insulin.
"It's still not entirely clear why obesity causes insulin resistance. Inflammation could be part of the reason why obesity leads to type 2 diabetes," said Emelie Wallerstedt from the Institute of Medicine at the University of Gothenburg.
Research has shown that both obesity and insulin resistance are affected by inflammatory conditions in the body.
Previously it was believed that fat tissue served merely as a depository for fat, but now scientists know that it is also an important organ for the release of a wide range of different substances, including inflammatory molecules.
In the new study, the researchers managed to identify the properties of the inflammatory molecule IL-6.
"IL-6 impairs insulin signalling, but the insulin signalling itself can also inhibit and ''turn off'' the IL-6 signal and inflammation. The protein PKCdelta also plays an important role in the regulation of the IL-6 signal, and we have shown that if we disable the function of this molecule, the inflammation decreases," Wallerstedt said.
A greater understanding of these signalling mechanisms could make it possible in the future to develop medicines that can "turn off" the inflammation and so reduce the risk of insulin resistance and other obesity-related disorders.
--
THE TIMES OF INDIA
Powered by INDIATIMES
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsDiabetes Advance: Gut Cells Changed Into Insulin Producers
Scientists have converted human gut cells into insulin producers by turning off a single gene in an experiment that suggests a novel way forward in treating diabetes. Using a miniature model of the human intestine, only…
4 July 2014
NewsInsulin, other drugs may do more harm than good for some type 2 diabetes patients
For patients with type 2 diabetes - especially those over age 50 - the negative impact of side effects like weight gain and burdens like frequent insulin shots trumps the benefits of drugs, says a new study by the…
1 July 2014
NewsNovel drug target linked to insulin secretion and type 2 diabetes treatment
A signal that promotes insulin secretion and reduces hyperglycemia in a type 2 diabetes animal model is enhanced by the inhibition of a novel enzyme discovered by CHUM Research Centre (CRCHUM) and University of Montreal…




